Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Trametinib

Cat. No.: OB0125LY-094
Appearance: Solid
Purity: 99.8%
Identity: Confirmed by NMR and HPLC.
Size:
Trametinib
Add to basket

Product Overview

Description: Trametinib is a MEK inhibitor that inhibits MEK1 and MEK2.
Synonym: 871700-17-3; N-[3-[3-Cyclopropyl-5-[ (2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1 (2H)-yl]phenyl]acetamide; N-(3-{3-Cyclopropyl-5-[ (2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1 (2H)-yl}phenyl)acetamide; N-(3-(3-Cyclopropyl-5-( (2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1 (2H)-yl)phenyl)acetamide; N-[3-[3-Cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
CAS No.: 871700-17-3
Compound CID: 11707110
Formula: C26H23FIN5O4
Formula Weight: 615.39

Specification

Targets & IC50: MEK1: 1.8 nM (cell free); MEK2: 0.92 nM (cell free)
Relative Density: 1.743 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Trametinib stops the growth of cancer cells by inhibiting the cell signaling pathway (MAPK pathway).

Library Information

Targets: Apoptosis; MEK; Autophagy
Receptors: Apoptosis; Autophagy; MEK; MEK1; MEK2
Pathways: Autophagy; Apoptosis; MAPK
Plate Number: AOCL-5
Plate Location: a2
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10 mM DMSO
DMSO Max Solubility: 7.86 mg/mL; 12.77 mM
Ethanol Max Solubility: 1 mg/mL
Saline Max Solubility: 2.1 mg/mL; 3.41 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.